Amylx Pharmaceuticals Inc vs KraneShares Electric Vehicles and Future Mobility — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while KraneShares Electric Vehicles and Future Mobility trades at $30.53. The key difference: Amylx Pharmaceuticals Inc is trading nearer its 52-week high, KraneShares Electric Vehicles and Future Mobility nearer its low. Which is the better fit depends on your goals.
| AMLX | KARS | |
|---|---|---|
Market Cap | $2.64B | — |
Sector | Health | Sector/Thematic |
52-Week High | $24.19 | $38.01 |
52-Week Low | $7.82 | $25.59 |
Enterprise Value | $2.39B | — |
Trailing returns across standard periods
Latest headlines on both assets
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →KARS invests in the global electric vehicle ecosystem and future mobility. It tracks the Bloomberg Electric Vehicles Index, providing exposure to EV manufacturers, battery technology, and lithium miners like Tesla, BYD, and Albemarle.
Read more on KARS →